- Quote, Chart, News
- Snapshot
- Company Report
- Quotes
- Charts
- Key Developments
Recent News- Research
- SEC Filings
- Advisor FYI
- CAPS
- StockScouter
- Earnings Estimates
- Analyst Ratings
- Financial Results
- Insider Trading
- Ownership
- Message Board
- Guided Research
- Research Wizard
- Find Stocks
- Stock Screener
- Stock Power Searches
- Top-Rated Stocks
- Related Links
- Quote Watchlist
- Expert Picks
- E-mail & Alerts
- IPO Center
- Message Boards
- Capital Gains Analysis
News resources
| Wal-Mart Stores Inc (WMT) | 44 stories... |
| Google Inc (GOOG) | 42 stories... |
| Citigroup Inc (C) | 38 stories... |
| Bank of America Corp (BAC) | 36 stories... |
| Amazon.com Inc (AMZN) | 35 stories... |
| advertisement |
AVI BioPharma Inc: All Recent News
- Market Report -- In Play (AVII) 11/19/2009
- AVI BioPharma presents update on AVI-4658 at TREAT-NMD / NIH international conference The co announces presentations on the company's exon skipping therapy for Duchenne muscular dystrophy at the... Briefing.com
- AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD /... 11/19/2009
- AVI BioPharma, Inc. (NASDAQ: AVII), a developerof RNA-based drugs, today announced presentations on the company's exonskipping therapy for Duchenne muscular dystrophy at the TREAT-NMD / NIHInternational Conference taking place Nov. 17-19 in Brussels, Belgium. Market Wire
- AVI BioPharma, Inc. to Present at Transformational Medical... 11/18/2009
- AVI BioPharma, Inc. (NASDAQ: AVII), a developerof RNA-based drugs, today announced that Patrick Iversen, Ph.D., SeniorVice President of Strategic Alliances, will present at the upcomingTransformational Medical Technologies Initiative (TMTI) Industry Day takingplace in Dallas, Texas. Market Wire
- AVI BioPharma Announces Third Quarter 2009 Financial Results &... 11/9/2009
- AVI BioPharma, Inc. (NASDAQ: AVII), a developerof RNA-based drugs, today reported financial results for the three and ninemonths ending September 30, 2009. The Company will host a conference calltoday, Monday, November 9, at 9:30 a.m. Eastern time (6:30 a.m. Pacific) toreview its financial results and corporate highlights (see below fordetails). Market Wire
- AVI BioPharma Announces Third Quarter 2009 Financial Results... 11/2/2009
- AVI BioPharma, Inc. (NASDAQ: AVII), a developerof RNA-based drugs, will hold a conference call to report third quarter2009 financial results on Monday, Nov. 9, 2009, at 9:30 a.m. Eastern time(6:30 a.m. Pacific time). Market Wire
- AVI BioPharma Presents Updated Safety Data From Ongoing... 10/26/2009
- AVI BioPharma, Inc. (NASDAQ: AVII), a developerof RNA-based drugs, presented an update on preliminary safety data from itsongoing systemic Phase 1b/2 clinical trial of exon skipping AVI-4658 inpatients with Duchenne muscular dystrophy (DMD) at the 7th Annual ActionDuchenne Conference in London, UK. Market Wire
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.